Autolus Therapeutics plc Quarterly Debt-to-equity in % from Q1 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Autolus Therapeutics plc quarterly Debt-to-equity history and growth rate from Q1 2020 to Q3 2024.
  • Autolus Therapeutics plc Debt-to-equity for the quarter ending September 30, 2024 was 74.2 %, a 13% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 74.2 -11.1 -13% Sep 30, 2024
Q2 2024 80.9 +6.79 +9.16% Jun 30, 2024
Q1 2024 93.4 +31.1 +49.8% Mar 31, 2024
Q4 2023 115 +63.3 +123% Dec 31, 2023
Q3 2023 85.3 +45 +111% Sep 30, 2023
Q2 2023 74.2 Jun 30, 2023
Q1 2023 62.3 Mar 31, 2023
Q4 2022 51.5 Dec 31, 2022
Q3 2022 40.3 Sep 30, 2022
Q1 2021 26.5 +9.21 +53.3% Mar 31, 2021
Q4 2020 26.8 Dec 31, 2020
Q3 2020 22.2 Sep 30, 2020
Q2 2020 18.3 Jun 30, 2020
Q1 2020 17.3 Mar 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.